Chemical Structure (Cedax 01)
Cedax
Product Images NDC 59630-821
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cedax (NDC 59630-821). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sciele Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (400 mg Capsule Label)
This is a prescription medication called Cedax, produced by Pharma Inc., a subsidiary of Shionogi Company. It contains Ceftibuten and is administered orally. The concentration of each capsule is 400mg. The rest of the text is not readable.*
Principal Display Panel (60 mL Carton)
The text seems to be a description of a medication called CEDAX, which is available in oral suspension form. It comes in a 60 mL bottle and needs to be reconstituted before use. The medication contains ceftibuten and is for prescription use only. The text also mentions something related to Varnish.*
Principal Display Panel (90 mL Carton)
CEDAX® is an oral suspension medication containing cefibuten when reconstituted. The product comes in a 90mL bottle and uses NDC code 50630-821-90. The rest of the text is not legible and appears to be distorted.*
Principal Display Panel (120 mL Carton)
Product Name: CEDAX (ceftibuten) oral suspension. NDC Number: 50630-821-12. It is an FDA approved medication available in 30g. Refer to product information for recommended dosage.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
